|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                              |                                               |                 |                                 |                         |                       |                                                  |                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|----------------------------------------------|-----------------------------------------------|-----------------|---------------------------------|-------------------------|-----------------------|--------------------------------------------------|-------------------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
| Three Months Ended September 30, 2022        |
| Percentage change versus the year-ago period |
|                                              | Reported(GAAP)Net SalesGrowth/ (Decrease) | Reported Volume | Acquisitions & Divestitures | Foreign Exchange Impact | PriceMix andOther (1) | OrganicSalesGrowth/ (Decrease)(Non-GAAP) (2) | OrganicVolume (3) |
| Health and Wellness                          | (4)%                                          | (21)%           | —%                        | —%                | 17%                   | (4)%                                             | (21)%             |
| Household                                    | (4)                                           | (14)            | —                         | —                 | 10                    | (4)                                              | (14)              |
| Lifestyle                                    | (3)                                           | (10)            | —                         | —                 | 7                     | (3)                                              | (10)              |
| International                                | (1)                                           | (4)             | —                         | (9)                     | 12                    | 8                                                | (4)               |
| Total                                        | (4)%                                          | (15)%           | —%                        | (2)%                    | 13%                   | (2)%                                             | (15)%             |

|                                                                                                                                                                                                                                                                                                                                                                                                      |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
|                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                      |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                      |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                      |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                      |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                      |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                      |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                      |
| (1) This represents the net impact on net sales growth/ (decrease) from pricing actions, mix and other factors.                                                                                                                                                                                                                                                                                  |
| (2) Organic sales growth/ (decrease) is defined as net sales growth/ (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See “Non-GAAP Financial Information” below for reconciliation of organic sales growth/ (decrease) to net sales growth/ (decrease), the most directly comparable GAAP financial information. |
| (3) Organic volume represents volume excluding the effect of any acquisitions and divestitures.                                                                                                                                                                                                                                                                                                      |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                                       |                                              |           |           |               |         |  |  |  |  |  |  |  |  |  |  |  |  |
|-------------------------------------------------------|----------------------------------------------|-----------|-----------|---------------|---------|--|--|--|--|--|--|--|--|--|--|--|--|
|                                                       | Three Months Ended September 30, 2022        |
|                                                       | Percentage change versus the year-ago period |
|                                                       | Health and Wellness                          | Household | Lifestyle | International | Total   |
| Net sales growth / (decrease) (GAAP)              | (4)%                                         | (4)%      | (3)%      | (1)%          | (4)%    |
| Add: Foreign Exchange                             | —                                      | —   | —   | 9             | 2       |
| Add/(Subtract): Divestitures/Acquisitions | —                                      | —   | —   | —       | — |
| Organic sales growth / (decrease) (non-GAAP)      | (4)%                                         | (4)%      | (3)%      | 8%            | (2)%    |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                               |                                                         |        |       |       |       |       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|-------------------------------|---------------------------------------------------------|--------|-------|-------|-------|-------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
| Driver                        | Gross Margin Change vs. Prior Year (basis points)  |        |       |
| FY22                          | FY23                                                    |        |       |
| Q1                            | Q2                                                      | Q3     | Q4    | FY    | Q1    |       |  |
| Cost Savings                  | +90                                                     | +80    | +100  | +160  | +110  | +180  |  |  |
| Price Changes                 | +50                                                     | +100   | +170  | +330  | +160  | +530  |  |  |
| Market Movement (commodities) | -550                                                    | -510   | -410  | -350  | -460  | -330  |  |  |
| Manufacturing & Logistics | -470                                                    | -640   | -570  | -290  | -490  | -350  |  |  |
| All other (1) (2)             | -210                                                    | -270   | -50   | +150  | -100  | -140  |  |  |
| Change vs prior year          | -1,090                                                  | -1,240 | -760  | 0     | -780  | -110  |  |  |
|                          |                                                    |        |       |       |       |       |  |  |
| Gross Margin (%)              | 37.1%                                                   | 33.0%  | 35.9% | 37.1% | 35.8% | 36.0% |  |  |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                                                  |                    |  |                          |  |  |  |  |  |  |  |  |
|------------------------------------------------------------------|--------------------|--|--------------------------|--|--|--|--|--|--|--|--|
|                                                             | Q1 Fiscal Year2023 |  | Q1 Fiscal Year 2022 |
| Net cash provided by operations – GAAP                     | $178               |  | $41                      |
| Less: Capital expenditures                                   | $46                |  | $52                      |
| Free cash flow – non-GAAP (1)                              | $132               |  | -$11                     |
| Free cash flow as a percentage of net sales – non-GAAP (1) | 7.6%               |  | (0.6)%                   |
| Net sales                                                        | $1,740             |  | $1,806                   |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                                                   |                   |        |                    |        |                   |        |                   |        |                   |       |                   |      |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|-------------------------------------------------------------------|-------------------|--------|--------------------|--------|-------------------|--------|-------------------|--------|-------------------|-------|-------------------|------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
|                                                              | FY 2022           |        | FY 2023            |
|                                                              |              |   |               |   |              |   |              |   |              |       |                   |
|                                                              | Q1                |        | Q2                 |        | Q3                |        | Q4                |        | FY                |       | Q1                |
|                                                              | 9/30/2021 |        | 12/31/2021 |        | 3/31/2022 |        | 6/30/2022 |        | 6/30/2022 |       | 9/30/2022 |
| Earnings before income taxes                                      | $185              |        | $93                |        | $200              |        | $129              |        | $607              |       | $116              |
| Interest income                                                   | -$1               |        | -$1                |        | -$1               |        | -$2               |        | -$5               |       | -$2               |
| Interest expense                                                  | $25               |        | $23                |        | $21               |        | $37               |        | $106              |       | $22               |
| EBIT(1)(3)                                                        | $209              |        | $115               |        | $220              |        | $164              |        | $708              |       | $136              |
| EBIT margin (1)(3)                                                | 11.6%             |        | 6.8%               |        | 12.2         | %      |                   | 9.1%   |                   | 10.0% |                   | 7.8% |
| Streamlined operating model (4)                                   | $0                |        | $0                 |        | $0                |        | $0                |        | $0                |       | $19               |
|                                                                   |                   |        |                    |        |                   |        |                   |        |                   |       |                   |
|                                                                   |                   |        |                    |        |                   |        |                   |        |                   |       |                   |
| Digital capabilities and productivity enhancements investment (5) | $12               |        | $15                |        | $15               |        | $19               |        | $61               |       | $20               |
| Adjusted EBIT – non-GAAP(2)(3)                              | $221              |   | $130               |        | $235              |        | $183              |        | $769              |       | $175              |
| Adjusted EBIT margin(2)(3)                                        | 12.2%             |        | 7.7%               |        | 13.0%             |        | 10.2%             |        | 10.8%             |       | 10.1%             |
| Net sales                                                         | $1,806            |        | $1,691             |        | $1,809            |        | $1,801            |        | $7,107            |       | $1,740            |
|                                                              |              |   |               |   |              |   |              |   |              |       |                   |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                                                   |  |                                          |      |         |          |      |       |  |  |  |  |  |  |  |  |  |  |  |  |  |
|-------------------------------------------------------------------|--|------------------------------------------|------|---------|----------|------|-------|--|--|--|--|--|--|--|--|--|--|--|--|--|
| (Dollars in millions except per share data)                       |  |
|                                                                   |  | Diluted Earnings per Share               |
|                                                                   |  | Three Months Ended September 30          |
|                                                                   |  | 2022                                     |      | 2021    | % Change |
|                                                                   |  |                                          |      |         |          |
| As reported (GAAP)                                                |  | $                                        | 0.68 |         | $        | 1.14 | (40)% |
| Streamlined operating model (1)                                   |  | 0.12                                     |      | — |          |
| Digital capabilities and productivity enhancements investment (2) |  | 0.13                                     |      | 0.07    |          |
| As adjusted (Non-GAAP)(5)(6)                                      |  | $                                        | 0.93 |         | $        | 1.21 | (23)% |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |
|                                                                   |  |                                          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  |                                          |      |         |          |
|                                                                   |  | Full Year 2023 Outlook (Estimated Range) |      |
|                                                                   |  | Diluted Earnings Per Share               |      |
|                                                                   |  | Low                                      |      | High    |          |
|                                                                   |  |                                          |      |         |          |
| As estimated (GAAP)                                               |  | $                                        | 3.10 |         | $        | 3.47 |       |
| Streamlined operating model (3)                                   |  | 0.20                                     |      | 0.20    |          |
| Digital capabilities and productivity enhancements investment(4)  |  | 0.55                                     |      | 0.55    |          |
| As adjusted (Non-GAAP)(5)(6)                                      |  | $                                        | 3.85 |         | $        | 4.22 |       |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |